Sign in

CIK 0000868278

  • Non-accelerated filer
  • Smaller reporting company

ProPhase Labs, Inc.

Sign in to watch
Ticker
PRPH
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
232577138
Phone
+1 215-345-0919
Business address
711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530
Former names
QUIGLEY CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-09-09 Karkus Ted William CEO & CHAIRMAN Grant or award · warrants +500,000 500,000
2025-02-17 Hollenshead Stuart Chief Operating Officer Grant or award · Option (right to buy) +500,000 500,000
2025-02-14 Hirsch Warren Director Grant or award · Option (right to buy) +100,000 100,000
2025-02-14 GLECKEL LOUIS MD Director Grant or award · Option (right to buy) +100,000 100,000
2024-03-17 Karkus Ted William CEO & CHAIRMAN Grant or award · Option (right to buy) +400,000 400,000
2024-03-17 Hirsch Warren Director Grant or award · Option (right to buy) +70,000 70,000
2024-03-17 GLECKEL LOUIS MD Director Grant or award · Option (right to buy) +70,000 70,000
2024-03-17 Barr Jason Michael Director Grant or award · Option (right to buy) +70,000 70,000
2024-03-17 Karkus Ted William CEO & CHAIRMAN Grant or award · Option (right to buy) −400,000 400,000
2024-01-01 Latkin Jed Director Grant or award · Option (right to buy) +500,000 500,000
2023-06-19 Hirsch Warren Director Grant or award · Option (right to buy) +40,000 40,000
2023-06-19 Barr Jason Michael Director Grant or award · Option (right to buy) +40,000 40,000
2023-06-19 GLECKEL LOUIS MD Director Grant or award · Option (right to buy) +40,000 40,000
2023-06-16 Hirsch Warren Director Grant or award · Option (right to buy) +40,000 40,000
2023-06-16 GLECKEL LOUIS MD Director Grant or award · Option (right to buy) +40,000 40,000
2023-06-16 Barr Jason Michael Director Grant or award · Option (right to buy) +40,000 40,000
2023-04-05 Karkus Ted William CEO & CHAIRMAN Gift −50,000 3,433,750
2023-04-05 Karkus Ted William CEO & CHAIRMAN Gift +50,000 150,000
2023-04-04 Morse Robert A. Jr. CHIEF FINANCIAL OFFICER Grant or award · Option (right to buy) +50,000 50,000
2023-04-03 Karkus Ted William CEO & CHAIRMAN Gift −100,000 3,483,750

Page 1 of 15 · 294 trades